Clinical Trial Update: Continuous Azithromycin in Cystic Fibrosis Patients Beyond Two Years

View source ↗

Summary

A completed clinical trial evaluating continuous azithromycin use in cystic fibrosis patients beyond two years (NCT02803944).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Cystic Fibrosis | Status: COMPLETED